Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Aquestive Therapeutics Inc’s stock clocked out at $2.54, down -4.15% from its previous closing price of $2.65. In other words, the price has decreased by -$4.15 from its previous closing price. On the day, 1.02 million shares were traded.
Ratios:
To gain a deeper understanding of AQST’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.36 and its Current Ratio is at 4.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on December 17, 2024, initiated with a Overweight rating and assigned the stock a target price of $17.
On May 10, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $8.
On April 11, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $10.Piper Sandler initiated its Overweight rating on April 11, 2024, with a $10 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 26 ’24 when Jung Cassie sold 44 shares for $4.87 per share. The transaction valued at 214 led to the insider holds 0 shares of the business.
Schobel Alexander Mark sold 50,000 shares of AQST for $300,000 on Mar 15 ’24. The Chief Innovation/Tech Officer now owns 984,476 shares after completing the transaction at $6.00 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.36.
Stock Price History:
Over the past 52 weeks, AQST has reached a high of $6.23, while it has fallen to a 52-week low of $2.24. The 50-Day Moving Average of the stock is -17.87%, while the 200-Day Moving Average is calculated to be -32.85%.
Shares Statistics:
A total of 91.41M shares are outstanding, with a floating share count of 87.68M. Insiders hold about 11.32% of the company’s shares, while institutions hold 38.70% stake in the company.
